Filter By “Lab / Genomic Data”
Privacy Frontiers in Health Data: Genomics (Part 2)
In Part 1 of this article, we discussed the evolving scientific landscape of disclosure risk in genetics data. In Part 2, we explore the legislative outcomes of this development. In particular, we will analyze the requirements of the HIPAA Omnibus Rule (2013) and propose a framework for how privacy experts should apply these in practice.
e-Book: Health Data Trends – Top Data Types in Demand
Over the last few years, connecting health data is evolving from innovation to standard practice. Pharmaceutical companies, health systems, government, payers, and analytics platforms connect data, creating a robust picture of patient health, to accelerate research, improve care, and lower healthcare costs.
e-Book: Health Data Trends Part II
This time, we’ll review new data available through Datavant’s ecosystem partners and its value in answering specific questions. As partners continue to join our ecosystem, there are more opportunities for health systems, insurers and biopharma companies to connect data that completes the picture of patient health.